Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide MDI vs systemic steroids in acute exacerbation of COPD (non-inferiority trial)
TCTR20201005006Phase 3Not yet recruiting
- Sponsor
- Siriraj Hospital
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide in chronic obstructive pulmonary disease (COPD), sponsored by Siriraj Hospital. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on TCTR20201005006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201005006.